Article Text

Download PDFPDF
Systematic review
Available evidence points to low effectiveness of influenza vaccines for older people

Statistics from

Request Permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.


  • Competing interests LS has received support from Pfizer for research related to pneumococcal vaccine and consulting fees from SDI, a health data analytics business.